| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly
|
Hu, Longbo
|
|
|
209 |
C |
p.
|
article
|
| 2 |
A stable hepatitis D virus-producing cell line for host target and drug discovery
|
Bach, Charlotte
|
|
|
209 |
C |
p.
|
article
|
| 3 |
Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy
|
Fang, Ren
|
|
|
209 |
C |
p.
|
article
|
| 4 |
Design and synthesis of a new series of hybrids of functionalised N 1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus
|
Głowacka, Iwona E.
|
|
|
209 |
C |
p.
|
article
|
| 5 |
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
|
Pérez-Vargas, Jimena
|
|
|
209 |
C |
p.
|
article
|
| 6 |
Editorial Board
|
|
|
|
209 |
C |
p.
|
article
|
| 7 |
Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model
|
Johnson, Dylan M.
|
|
|
209 |
C |
p.
|
article
|
| 8 |
Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles
|
Zimna, Marta
|
|
|
209 |
C |
p.
|
article
|
| 9 |
Hepatitis D virus: Improving virological knowledge to develop new treatments
|
Khalfi, Pierre
|
|
|
209 |
C |
p.
|
article
|
| 10 |
Implications of the antiviral drug favipiravir on rabies immunoglobulin for post-exposure prophylaxis of rabies in mice model with category III-like exposures
|
Kimitsuki, Kazunori
|
|
|
209 |
C |
p.
|
article
|
| 11 |
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus
|
Lamrayah, Myriam
|
|
|
209 |
C |
p.
|
article
|
| 12 |
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
|
Faist, Aileen
|
|
|
209 |
C |
p.
|
article
|
| 13 |
Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster
|
Zhang, Ya-Nan
|
|
|
209 |
C |
p.
|
article
|
| 14 |
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus
|
Parsons, Andrea J.
|
|
|
209 |
C |
p.
|
article
|
| 15 |
In vitro and in vivo effects of 3-indoleacetonitrile—A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection
|
Hui, Xianfeng
|
|
|
209 |
C |
p.
|
article
|
| 16 |
ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway
|
Yang, Qingyu
|
|
|
209 |
C |
p.
|
article
|
| 17 |
Multiplication of defective Ebola virus in a complementary permissive cell line
|
Tong, Xian-Kun
|
|
|
209 |
C |
p.
|
article
|
| 18 |
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro
|
Chistov, Alexey A.
|
|
|
209 |
C |
p.
|
article
|
| 19 |
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1
|
Hashizume, Mei
|
|
|
209 |
C |
p.
|
article
|
| 20 |
PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected mice
|
Tang, Yuling
|
|
|
209 |
C |
p.
|
article
|
| 21 |
Preclinical characterization of ABI-H2158, an HBV core inhibitor with dual mechanisms of action
|
Yan, Ran
|
|
|
209 |
C |
p.
|
article
|
| 22 |
Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay
|
Jeong, Kwiwan
|
|
|
209 |
C |
p.
|
article
|
| 23 |
RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5ʹ-untranslated region
|
Yao, Yongxuan
|
|
|
209 |
C |
p.
|
article
|
| 24 |
Targeting 7-dehydrocholesterol reductase against EV-A71 replication by upregulating interferon response
|
Wang, Huiqiang
|
|
|
209 |
C |
p.
|
article
|
| 25 |
The life cycle of the alphaviruses: From an antiviral perspective
|
Skidmore, Andrew M.
|
|
|
209 |
C |
p.
|
article
|
| 26 |
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N 4 -Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection
|
Bluemling, Gregory R.
|
|
|
209 |
C |
p.
|
article
|
| 27 |
Therapeutic targeting of organelles for inhibition of Zika virus replication in neurons
|
Ojha, Durbadal
|
|
|
209 |
C |
p.
|
article
|
| 28 |
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease
|
Welch, Stephen R.
|
|
|
209 |
C |
p.
|
article
|
Journal description